Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7068618 | 1.00 | LMNA (0.37) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL7144047 | 1.00 | LMNA (0.37) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL6870720 | 1.00 | LMNA (0.37) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL27671076 | 1.00 | LMNA (0.37) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL626496 | 1.00 | LMNA (0.37) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL9734750 | 0.98 | LMNA (0.36) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL14808559 | 0.96 | LMNA (0.39) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL92768 | 0.94 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL2015790 | 0.94 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL215095 | 0.94 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118420693-A | 6- (Isopropyl disulfide) -guanosine compound, and preparation method and application thereof | 浙江大学金华研究院 | 2024-08-02 | — | — | CN | claimed |
| CN-114276393-A | Preparation process of beta-nicotinamide riboside chloride | 南京诺云生物科技有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-118420693-A | 6- (Isopropyl disulfide) -guanosine compound, and preparation method and application thereof | 浙江大学金华研究院 | 2024-08-02 | — | — | CN | disclosed |
| CN-117940567-A | Antisense compounds that modulate the expression of WFDC2 | 克迈恩有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-113755415-B | Novel recombinant microorganism with NMN synthesis path and production method thereof | 苏州华赛生物工程技术有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-113755413-B | Recombinant microorganism for producing beta-nicotinamide mononucleotide and method for producing NMN by using same | 苏州华赛生物工程技术有限公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-114807078-B | Method for biosynthesis of NMN | 四川盈嘉合生科技有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-113755411-B | Recombinant microorganism for high-yield of beta-nicotinamide mononucleotide and method for producing beta-nicotinamide mononucleotide by recombinant microorganism | 苏州华赛生物工程技术有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-112961890-B | Enzymatic synthesis method of nicotinamide mononucleotide | 深圳希吉亚生物技术有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-111676204-B | Nicotinamide phosphoribosyl transferase for preparing nicotinamide mononucleotide, coding gene, vector and application | 成都及禾生物科技有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-110590879-B | Acridinone derivatives containing ribose or deoxyribose sugar structure and preparation method and application thereof | 河南师范大学 | 2022-12-27 | — | — | CN | disclosed |
| CN-111676204-A | Nicotinamide phosphoribosyl transferase for preparing nicotinamide mononucleotide, coding gene, carrier and application | 成都及禾生物科技有限公司 | 2020-09-18 | — | — | CN | disclosed |
| CN-109666658-B | Nicotinamide phosphoribosyl transferase for preparing NMN, coding gene, recombinant vector and application | 成都及禾生物科技有限公司 | 2020-08-04 | — | — | CN | disclosed |
| US-7521432-B2 | Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-04-21 | — | — | US | disclosed |
| US-7291606-B2 | Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging | WISCONSON ALUMNI RESEARCH FOUNDATION (US) | 2007-11-06 | — | — | US | disclosed |
| US-20070255045-A1 | COMPOSITIONS AND METHODS FOR IDENTIFYING AGENTS WHICH REGULATE CHROMOSOMAL STABILITY, GENE ACTIVATION AND AGING | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2007-11-01 | — | — | US | disclosed |
| US-20070225246-A1 | O-acetyl-ADP-ribose non-hydrolyzable analogs | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-09-27 | — | — | US | disclosed |
| WO-2005016878-A2 | METHODS FOR THE PREPARATION OF 5-FLUORO-PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 2005-02-24 | — | — | WO | disclosed |
| US-20040067228-A1 | Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2004-04-08 | — | — | US | disclosed |
| WO-2002038579-A1 | COMPOSITIONS AND METHODS FOR IDENTIFYING AGENTS WHICH REGULATE CHROMOSOMAL STABILITY, GENE ACTIVATION AND AGING | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2002-05-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225246-A1 | O-acetyl-ADP-ribose non-hydrolyzable analogs | PARP1, TIPARP, CD38 | LMNA 1670/4885L3MBTL1 1225/4885PDE4A 2188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.